I think IMU paid $9M upfront and then spent $10M on the manufacturing plant expense before offloading the cost which mean already $19M out of the total $50M CR for the Azer-Cel acquisition has been spent. So IMU will be diverting the $30M remainder of the CR to VAXINIA and OASIS clinical trials cost for the next few years. Only positive is a CR will likely not be required for a while but then there will be no benefit of the Azer-Cel IP for any T/O now.
I think IMU paid $9M upfront and then spent $10M on the...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |